These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 27162247)

  • 1. Synthesis and characterization of Fe
    Arami S; Rashidi MR; Mahdavi M; Fathi M; Entezami AA
    Hum Exp Toxicol; 2017 Mar; 36(3):227-237. PubMed ID: 27162247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis induction activity and molecular docking studies of survivin siRNA carried by Fe
    Arami S; Mahdavi M; Rashidi MR; Yekta R; Rahnamay M; Molavi L; Hejazi MS; Samadi N
    J Pharm Biomed Anal; 2017 Aug; 142():145-154. PubMed ID: 28505590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-based nanoparticles for survivin targeted siRNA delivery in breast tumor therapy and preventing its metastasis.
    Sun P; Huang W; Jin M; Wang Q; Fan B; Kang L; Gao Z
    Int J Nanomedicine; 2016; 11():4931-4945. PubMed ID: 27729789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes.
    Jin M; Jin G; Kang L; Chen L; Gao Z; Huang W
    Int J Nanomedicine; 2018; 13():2405-2426. PubMed ID: 29719390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Superparamagnetic Nanoparticles: From Synthesis to siRNA Delivery.
    Arami S; Mahdavi M; Rashidi MR; Fathi M; Hejazi MS; Samadi N
    Curr Pharm Des; 2017; 23(16):2400-2409. PubMed ID: 27799034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation and characterization of β-cyclodextrin (β-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug.
    Prabha G; Raj V
    Biomed Pharmacother; 2016 May; 80():173-182. PubMed ID: 27133054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Small interfering RNA delivery mediated by mPEG-PCL-g-PEI polymer nanoparticles].
    Huang W; Lü M; Gao ZG; Jin MJ; Yang CQ
    Yao Xue Xue Bao; 2011 Mar; 46(3):344-9. PubMed ID: 21626792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy.
    Li TS; Yawata T; Honke K
    Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-tumor effects in mice induced by survivin-targeted siRNA delivered through polysaccharide nanoparticles.
    Yang F; Huang W; Li Y; Liu S; Jin M; Wang Y; Jia L; Gao Z
    Biomaterials; 2013 Jul; 34(22):5689-99. PubMed ID: 23632321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The investigation of polymer-siRNA nanoparticle for gene therapy of gastric cancer in vitro.
    Wu Y; Wang W; Chen Y; Huang K; Shuai X; Chen Q; Li X; Lian G
    Int J Nanomedicine; 2010 Mar; 5():129-36. PubMed ID: 20309399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-homing glycol chitosan/polyethylenimine nanoparticles for the systemic delivery of siRNA in tumor-bearing mice.
    Huh MS; Lee SY; Park S; Lee S; Chung H; Lee S; Choi Y; Oh YK; Park JH; Jeong SY; Choi K; Kim K; Kwon IC
    J Control Release; 2010 Jun; 144(2):134-43. PubMed ID: 20184928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J; Feng SS; Wang S; Chen ZY
    Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy.
    Lu ZX; Liu LT; Qi XR
    Int J Nanomedicine; 2011; 6():1661-73. PubMed ID: 21904456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chitosan-graft-(PEI-β-cyclodextrin) copolymers and their supramolecular PEGylation for DNA and siRNA delivery.
    Ping Y; Liu C; Zhang Z; Liu KL; Chen J; Li J
    Biomaterials; 2011 Nov; 32(32):8328-41. PubMed ID: 21840593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel biotinylated chitosan-graft-polyethyleneimine copolymer as a targeted non-viral vector for anti-EGF receptor siRNA delivery in cancer cells.
    Darvishi MH; Nomani A; Amini M; Shokrgozar MA; Dinarvand R
    Int J Pharm; 2013 Nov; 456(2):408-16. PubMed ID: 24012865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of cationic polymer-siRNA nanoparticles for gene therapies in neural regeneration.
    Liang Y; Liu Z; Shuai X; Wang W; Liu J; Bi W; Wang C; Jing X; Liu Y; Tao E
    Biochem Biophys Res Commun; 2012 May; 421(4):690-5. PubMed ID: 22542938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.
    Riehle R; Pattni B; Jhaveri A; Kulkarni A; Thakur G; Degterev A; Torchilin V
    Pharm Res; 2016 Jul; 33(7):1587-601. PubMed ID: 26951567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel polyacrylate-based cationic nanoparticles for survivin siRNA delivery combined with mitoxantrone for treatment of breast cancer.
    Arami S; Mahdavi M; Rashidi MR; Fathi M; Hejazi MS; Samadi N
    Biologicals; 2016 Nov; 44(6):487-496. PubMed ID: 27712979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted silencing of Survivin in cancer cells by siRNA loaded chitosan magnetic nanoparticles.
    Unsoy G; Gunduz U
    Expert Rev Anticancer Ther; 2016 Jul; 16(7):789-97. PubMed ID: 27130312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.